Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "social"

329 News Found

Beyond beds and buildings: The quiet capital shift reshaping healthcare
Opinion | April 17, 2026

Beyond beds and buildings: The quiet capital shift reshaping healthcare

The investment case for health technology in India is frequently overstated in one direction and understated in another


Erin Lichy teams with Allergan Aesthetics to open up about breast augmentation
News | April 16, 2026

Erin Lichy teams with Allergan Aesthetics to open up about breast augmentation

Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms


Teva launches Home Ground platform to tackle isolation in schizophrenia care
Digitisation | April 16, 2026

Teva launches Home Ground platform to tackle isolation in schizophrenia care

The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping


Zydus improves ESG rating to 68, up from 66 last year
News | April 11, 2026

Zydus improves ESG rating to 68, up from 66 last year

The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker


HCG Bengaluru pushes distress screening as ‘6th vital sign’ in cancer care
Hospitals | April 09, 2026

HCG Bengaluru pushes distress screening as ‘6th vital sign’ in cancer care

The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment


The Semaglutide Surge: How a diabetes therapy sparked India’s weight loss wave
Healthcare | April 07, 2026

The Semaglutide Surge: How a diabetes therapy sparked India’s weight loss wave

As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact


Vedanta’s community healthcare programmes reach 30 lakh people, FY26 spend crosses Rs 50 crore
News | April 07, 2026

Vedanta’s community healthcare programmes reach 30 lakh people, FY26 spend crosses Rs 50 crore

The last-mile healthcare delivery across 1,100 villages, with focus on maternal health, diagnostics, and chronic disease management


Vyome Holdings bolsters financial position to support VT-1953 pivotal study through 2027
Biotech | April 02, 2026

Vyome Holdings bolsters financial position to support VT-1953 pivotal study through 2027

As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million


Alembic receives USFDA final approval for Paroxetine Extended-Release Tablets
Drug Approval | March 28, 2026

Alembic receives USFDA final approval for Paroxetine Extended-Release Tablets

Paroxetine extended-release tablets are indicated for the treatment of major depressive disorder